Search

everythinglearnresearchcommunity

for

Search:↓

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Finasteride improves acne and hair loss in women with normal testosterone.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Women with PCOS often have more sleep problems than the general population.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Young women with PCOS and no other heart risk factors have normal heart function.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.